A new drug, lecanemab, has been approved by the US Food and Drug Administration “for treating Alzheimer’s disease.” The drug “slowed cognitive decline in patients with early Alzheimer’s disease.” According to Dr. Dennis Selkoe, Harvard Medical School professor, “For the first time in human history, we have an agent that can actually treat people with Alzheimer’s in a way that could slow their cognitive decline. We’ve never been able to say those words until the last few months.”
New Alzheimer’s Drug to Prevent Damage to the Brain
Join the AGEIST movement!
Sign-up for our weekly magazine.
See medical disclaimer below.
The ideas expressed here are solely the opinions of the author and are not researched or verified by AGEIST LLC, or anyone associated with AGEIST LLC. This material should not be construed as medical advice or recommendation, it is for informational use only. We encourage all readers to discuss with your qualified practitioners the relevance of the application of any of these ideas to your life. The recommendations contained herein are not intended to diagnose, treat, cure or prevent any disease. You should always consult your physician or other qualified health provider before starting any new treatment or stopping any treatment that has been prescribed for you by your physician or other qualified health provider. Please call your doctor or 911 immediately if you think you may have a medical or psychiatric emergency.